Highlights Genscript Biotech Corporation

Stocks

1548

KYG3825B1059

Biotechnology & Medical Research

Delayed Hong Kong S.E. Other stock markets 08:23:56 11/06/2026 BST			5-day change	1st Jan Change
11.72 ^HKD	+0.69%		-10.08%	-5.96%

06-03	Genscript Associate to Present Data for Lymphoma Drug at European Conference; Shares Surge 11%	MT
06-03	Genscript Biotech Defends Operations Amid Renewed U.S. Lawmaker Scrutiny	MT

Highlights

06-03	Genscript Biotech Defends Operations Amid Renewed U.S. Lawmaker Scrutiny	MT
05-12	Genscript Biotech Corporation Launches Turbocho Protein Expression Kit	CI
03-16	Genscript Biotech Corp reports strong FY2025 results as integrated platform strategy and global execution drive high-quality growth	RE
03-16	Genscript Biotech Books 2025 Loss Despite 61% Growth in Revenue	MT
03-15	Genscript Biotech Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-12	GenScript Opens First European mRNA Production Site in Delft, Netherlands	CI
03-11	Genscript Biotech Forecasts 2025 Loss	MT
03-10	Genscript Biotech expects FY2025 adjusted net profit of US$207.3 million-US$241.9 million	RE
03-10	Genscript Biotech Corporation Provides Earnings Guidance for the Year Ended 31 December 2025	CI
15/10/25	GenScript Associate Books $524 Million in Q3 CARVYKTI Sales	MT
17/08/25	Genscript Biotech Corporation Reports Earnings Results for the Half Year Ended June 30, 2025	CI
08/08/25	GenScript Biotech Corporation Unveils New Global Identity: "Scripting Possibilities" to Power the Future of Biotechnology	CI
22/07/25	Genscript Expects to Swing to H1 Profit	MT
22/07/25	Genscript Biotech expects profit before tax of $175.4m-$204.6m in HY	RE
22/07/25	Genscript Biotech Corporation Provides Group Earnings Guidance for the Six Months Ended June 30, 2025	CI
30/06/25	Genscript Biotech Corporation's Zhenjiang ProBio Biotech Co., Limited and ProBio Nanjing Receives Payments of Approximately USD 213.8 Million Under the R&A Agreement	CI
04/06/25	Genscript Biotech Corporation Announces New 5-Year Survey Data for Carvykti in Cartitude-1 Study for Multiple Myeloma at 2025	CI
19/03/25	GenScript Unveils Prime Editing Boost with the Broad Institute Deal	CI
12/03/25	Genscript Biotech Swings to Profit in 2024; Shares Down 4%	MT
11/03/25	Genscript Biotech Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	CI
17/02/25	Genscript Biotech Expects Higher 2024 Net Profit	MT
16/02/25	Genscript Biotech Corporation Provides Earnings Guidance for the Year Ended 31 December 2024	CI
23/01/25	Genscript Biotech's Associate Logs $334 Million in Carvykti Drug Sales in Q4	MT
15/11/24	Genscript Biotech Enters Sub-License Contract for Anti-PD-1 Single Domain Antibodies	MT
13/11/24	Genscript Bio Associate Legend Biotech's Loss Doubles in Q3	MT